Aurisco Pharmaceutical Co Ltd Free Cash Flow Generation Index
Aurisco Pharmaceutical Co Ltd free cash flow generation index. Aurisco Pharmaceutical Co Ltd (605116) has a Free Cash Flow Generation Index of -0.63x as of December 2024. Free cash flow of CN¥-207.87 Million represents -1% of operating cash flow (CN¥332.41 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Aurisco Pharmaceutical Co Ltd (2017–2024)
Free cash flow generation index of Aurisco Pharmaceutical Co Ltd from 2017 to 2024. Historical FCF Generation Index trend for Aurisco Pharmaceutical Co Ltd across 8 annual periods. See how financially flexible is Aurisco Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Aurisco Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2017–2024)
Aurisco Pharmaceutical Co Ltd free cash flow generation index by year from 2017 to 2024. Year-by-year Free Cash Flow Generation Index for Aurisco Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Aurisco Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.63x | CN¥-207.87 Million | CN¥332.41 Million | CN¥540.28 Million | ▼ -400.9% |
| 2023 | 0.21x | CN¥80.13 Million | CN¥385.61 Million | CN¥305.48 Million | ▲ +169.4% |
| 2022 | -0.30x | CN¥-49.82 Million | CN¥166.41 Million | CN¥216.23 Million | ▼ -23.0% |
| 2021 | -0.24x | CN¥-49.04 Million | CN¥201.57 Million | CN¥250.61 Million | ▼ -193.7% |
| 2020 | 0.26x | CN¥55.68 Million | CN¥214.48 Million | CN¥158.80 Million | ▼ -56.5% |
| 2019 | 0.60x | CN¥107.43 Million | CN¥179.90 Million | CN¥72.47 Million | ▲ +319.5% |
| 2018 | 0.14x | CN¥15.63 Million | CN¥109.77 Million | CN¥94.14 Million | ▲ +48.4% |
| 2017 | 0.10x | CN¥11.31 Million | CN¥117.91 Million | CN¥106.60 Million | — |